Verastem (VSTM) Return on Invested Capital (2024 - 2025)

Verastem's (VSTM) quarterly Return on Invested Capital came in at 0.13% in Q2 2025, down 43.25% quarter-over-quarter from 0.09% in Q1 2025.

Verastem (VSTM) Return on Invested Capital (2024 - 2025) Analysis & Trends

Verastem's Return on Invested Capital history runs 2 years deep, the most recent figure standing at 0.13% for Q2 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	ROIC (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	0.00%
4	NuCana	279.75 Bn	279.75 Bn	-	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	-
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	0.04%
7	Belite Bio	62.51 Bn	62.51 Bn	-	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	-
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	-
10	Verastem	166.09 Mn	-31.73 Mn	15.90 Mn	-

Download Data